Skip to main content

1 Result(s)

within Pengjiu Yu Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    FOXC2 promotes epithelial–mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells

    Platinum-based drugs, particularly cisplatin (DDP), are used in the treatment of non-small cell lung cancer (NSCLC). However, development of drug resistance remains the major therapeutic barrier in NSCLC.

    Yuwen He, Hui **e, Pengjiu Yu, Shunjun Jiang… in Cancer Chemotherapy and Pharmacology (2018)